Medidata Solutions Inc (NASDAQ:MDSO) Director Robert Taylor sold 2,120 shares of the company’s stock in a transaction on Monday, January 7th. The stock was sold at an average price of $64.70, for a total transaction of $137,164.00. Following the completion of the sale, the director now owns 41,916 shares of the company’s stock, valued at approximately $2,711,965.20. The transaction was disclosed in a filing with the SEC, which is available through this link.
MDSO opened at $68.48 on Friday. The stock has a market cap of $4.13 billion, a P/E ratio of 70.29, a P/E/G ratio of 4.00 and a beta of 1.32. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.52 and a quick ratio of 2.52. Medidata Solutions Inc has a fifty-two week low of $59.60 and a fifty-two week high of $88.87.
Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Thursday, October 18th. The company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.06. The company had revenue of $163.41 million during the quarter, compared to analyst estimates of $162.09 million. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The firm’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.33 earnings per share. Analysts predict that Medidata Solutions Inc will post 0.85 earnings per share for the current year.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Retirement Systems of Alabama lifted its holdings in Medidata Solutions by 2.0% during the fourth quarter. Retirement Systems of Alabama now owns 111,618 shares of the company’s stock valued at $7,525,000 after purchasing an additional 2,197 shares during the last quarter. Vanguard Group Inc lifted its holdings in Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc now owns 5,200,744 shares of the company’s stock valued at $381,266,000 after purchasing an additional 142,687 shares during the last quarter. Marshall Wace LLP purchased a new stake in Medidata Solutions during the third quarter valued at about $575,000. Clearbridge Investments LLC lifted its holdings in Medidata Solutions by 5.9% during the third quarter. Clearbridge Investments LLC now owns 2,429,627 shares of the company’s stock valued at $178,116,000 after purchasing an additional 135,078 shares during the last quarter. Finally, Carnegie Capital Asset Management LLC lifted its holdings in Medidata Solutions by 90.5% during the third quarter. Carnegie Capital Asset Management LLC now owns 16,420 shares of the company’s stock valued at $1,188,000 after purchasing an additional 7,800 shares during the last quarter.
TRADEMARK VIOLATION NOTICE: This report was reported by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://dakotafinancialnews.com/2019/01/11/insider-selling-medidata-solutions-inc-mdso-director-sells-2120-shares-of-stock.html.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.